Zobrazeno 1 - 10
of 434
pro vyhledávání: '"Krishan R"'
Autor:
Christopher L. Hallemeier, MD, Kenneth W. Merrell, MD, Michelle A. Neben-Wittich, MD, Krishan R. Jethwa, MD, Harry H. Yoon, MD, Henry C. Pitot, MD, Shanda Blackmon, MD, K. Robert Shen, MD, Erik J. Tryggestad, PhD, Broc Giffey, CMD, Bret D. Kazemba, CMD, Jason K. Viehman, MS, William S. Harmsen, MS, Michael G. Haddock, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 8, Pp 101547- (2024)
Purpose: To evaluate the safety and efficacy of pencil beam scanning (PBS) proton radiation therapy (RT) in trimodality therapy for esophageal cancer. Methods and Materials: This prospective pilot study was planned to accrue 30 patients with locally
Externí odkaz:
https://doaj.org/article/e6c33f8f9d8a495f9155ba7f53fa443f
Autor:
Conor D. J. O’Donnell, Nikolas Naleid, Teerada Siripoon, Kevin G. Zablonski, Michael H. Storandt, Jennifer E. Selfridge, Christopher L. Hallemeier, Madison L. Conces, Krishan R. Jethwa, David L. Bajor, Cornelius A. Thiels, Susanne G. Warner, Patrick P. Starlinger, Thomas D. Atwell, Jessica L. Mitchell, Amit Mahipal, Zhaohui Jin
Publikováno v:
Cancers, Vol 16, Iss 13, p 2407 (2024)
(1) Background: Local therapies offer a potentially curative approach for patients with oligometastatic colorectal cancer (CRC). An evidence-based consensus recommendation for systemic therapy following definitive locoregional therapy is lacking. Tum
Externí odkaz:
https://doaj.org/article/bca9a985851e4b8fbf04827e744c4e89
Autor:
Vikram Jairam, MD, Henry S. Park, MD, MPH, James B. Yu, MD, MHS, Ranjit S. Bindra, MD, PhD, Joseph N. Contessa, MD, PhD, Krishan R. Jethwa, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100949- (2022)
Purpose: Whole brain radiation therapy (WBRT) is often used as an effective treatment for patients with brain metastasis, although it is also known to have deleterious cognitive effects. Multiple trials have identified strategies to help mitigate neu
Externí odkaz:
https://doaj.org/article/389557bb2c944e3192dd5e542207ba5b
Autor:
Elizabeth B. Jeans, Daniel K. Ebner, Hirotoshi Takiyama, Kaitlin Qualls, Danielle A. Cunningham, Mark R. Waddle, Krishan R. Jethwa, William S. Harmsen, Joleen M. Hubbard, Eric J. Dozois, Kellie L. Mathis, Hiroshi Tsuji, Kenneth W. Merrell, Christopher L. Hallemeier, Anita Mahajan, Shigeru Yamada, Robert L. Foote, Michael G. Haddock
Publikováno v:
Cancers, Vol 15, Iss 11, p 3057 (2023)
No standard treatment paradigm exists for previously irradiated locally recurrent rectal cancer (PILRRC). Carbon-ion radiotherapy (CIRT) may improve oncologic outcomes and reduce toxicity compared with combined modality therapy (CMT). Eighty-five pat
Externí odkaz:
https://doaj.org/article/9c31744cd5b94a078b9b0414a9f7036c
Autor:
Krupa S. Jani, Shou‐En Lu, James D. Murphy, Paul B. Romesser, Krishan R. Jethwa, Diana Li, Anupama Chundury, Abraham J. Wu, Lara Hathout, Christopher L. Hallemeier, Salma K. Jabbour
Publikováno v:
Cancer Medicine, Vol 10, Iss 11, Pp 3575-3583 (2021)
Abstract Background Increased risk of a second primary malignancy (SPM) before or after diagnosis of anal squamous cell carcinoma (ASCC) has been reported in a previous single‐institution study. We hypothesize that patients diagnosed with ASCC are
Externí odkaz:
https://doaj.org/article/96613193e64644aaafcb06d3af3560da
Autor:
Krishan R. Jethwa, Courtney N. Day, Harigopal Sandhyavenu, Karthik Gonuguntla, William S. Harmsen, William G. Breen, David M. Routman, Allison E. Garda, Joleen M. Hubbard, Thorvardur R. Halfdanarson, Michelle A. Neben-Wittich, Kenneth W. Merrell, Christopher L. Hallemeier, Michael G. Haddock
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 28, Iss , Pp 17-23 (2021)
Introduction: To report long-term efficacy and adverse events (AEs) associated with intensity modulated radiotherapy (IMRT) for patients with anal canal squamous cell carcinoma (ASCC). Materials and methods: This was a retrospective review of patient
Externí odkaz:
https://doaj.org/article/f80ea376971d4cb7a9c61ec994194be0
Autor:
Joseph A. Miccio, Wesley J. Talcott, Timil Patel, Henry S. Park, Michael Cecchini, Ronald R. Salem, Sajid A. Khan, Stacey Stein, Jeremy S. Kortmansky, Jill Lacy, Amol Narang, Joseph Herman, Salma K. Jabbour, Christopher L. Hallemeier, Kimberly Johung, Krishan R. Jethwa
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss , Pp 15-23 (2021)
Purpose: Margin-negative (R0) resection is the only potentially curative treatment for patients with pancreatic ductal adenocarcinoma (PDAC). Pre-operative multi-agent chemotherapy alone (MAC) or MAC followed by pre-operative radiotherapy (MAC + RT)
Externí odkaz:
https://doaj.org/article/6cbac6a58777403cbed48d1acbe64aa0
Autor:
Elizabeth B. Jeans, MEd, MD, Krishan R. Jethwa, MD, William S. Harmsen, MS, Michelle Neben-Wittich, MD, Jonathan B. Ashman, MD, Kenneth W. Merrell, MD, Broc Giffey, CMD, Shima Ito, MS, Bret Kazemba, CMD, Chris Beltran, PhD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 865-870 (2020)
Purpose: For treatment of rectal cancer, pencil beam scanning proton therapy (PBS-PT) may reduce radiation exposure to normal tissues compared with 3-dimensional conformal photon radiation therapy (3DCRT) or volumetric modulated arc photon radiation
Externí odkaz:
https://doaj.org/article/57dc62f2458743e29986b7f55f51e7f9
Autor:
Wei Deng, MD, Krishan R. Jethwa, MD, Karthik Gonuguntla, MD, Zhongxing Liao, MD, Harry H. Yoon, MD, Mariela Blum Murphy, MD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD, Steven H. Lin, MD PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 951-958 (2020)
Purpose: To evaluate the safety and efficacy of definitive chemoradiotherapy (CRT) for patients with clinical T1N0M0 esophageal adenocarcinoma. Methods and Materials: This was a retrospective study of patients with clinical T1N0 adenocarcinoma of the
Externí odkaz:
https://doaj.org/article/c49f54d9fa6b428ab649943d058b8c26
Autor:
Jaden D. Evans, MD, Riley H. Harper, BS, Molly Petersen, MS, William S. Harmsen, MS, Aman Anand, PhD, Ashley Hunzeker, CMD, Noelle C. Deiter, RTT, Heather Schultz, CMD, Krishan R. Jethwa, MD, Scott C. Lester, MD, David M. Routman, MD, Daniel J. Ma, MD, Yolanda I. Garces, MD, Michelle A. Neben-Wittich, MD, Nadia N. Laack, MD, Chris J. Beltran, PhD, Samir H. Patel, MD, Lisa A. McGee, MD, Jean-Claude M. Rwigema, MD, Daniel W. Mundy, PhD, Robert L. Foote, MD
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 1, Pp 41-53 (2020)
Purpose: To understand how verification computed tomography-quality assurance (CTQA) scans influenced clinical decision-making to replan patients with head and neck cancer and identify predictors for replanning to guide intensity-modulated proton the
Externí odkaz:
https://doaj.org/article/7c82f8da3f5d411aa8efb72d2b1a9052